Stocks Screeners Features Pricing
Sign In Get Started

Synopsys Stock Analysis

NASDAQ: SNPS | Information Technology | Application Software
Price $392.07 +$3.31 (+0.85%)
P/E Ratio 56.5 TTM
52-Week Range
Low $366 High $637
Market Cap $63.39B USD
ROE 4.7% Annual

Market data as of Aug 3, 2026 · Financials as of Oct 2025

Published Jun 8, 2026 · Updated Jun 9, 2026

What do the numbers say about Synopsys (SNPS)? Here's a look at its financials, capital returns, and valuation.

Top-Line Growth

Year-over-year, Synopsys grew revenue by 15.1% — from $6.13B in FY2024 to $7.05B in FY2025.

Synopsys has compounded revenue at 12.1% over 10 years — good, consistent top-line expansion from $2.24B to $7.05B.

In terms of scale, Synopsys's $7.05B in annual revenue positions it as a mid-cap information technology company.

With 10 straight years of revenue growth, this isn't a blip — the trajectory is clear for Synopsys.

Revenue Trend
Year Revenue YoY %
FY2025 $7.05B +15.1%
FY2024 $6.13B +15.2%
FY2023 $5.32B +15.2%
FY2022 $4.62B +9.8%
FY2021 $4.20B +14.1%

Dive deeper into Synopsys's top-line performance

Business Segments

Looking under the hood at Synopsys's revenue mix for FY2025.

Synopsys Business Segment Performance (FY2025)

License and Maintenance49.5% · $3.49B
License28.5% · $2.01B
Technology Service22.0% · $1.55B
SegmentRevenue% of Total
License and Maintenance$3.49B49.5%
License$2.01B28.5%
Technology Service$1.55B22.0%

At 49.5% of total revenue, License and Maintenance is by far Synopsys's largest segment.

The License segment is gaining share, growing 11.6% and now accounting for 28.5% of revenue.

Notably, Technology Service grew 41.2% YoY, taking its share to 22.0% of total revenue.

Geographically, Synopsys's revenue is split across United States (44%), Other Countries (18%), South Korea (13%), Europe (13%), and China (12%).

Synopsys Earnings & Margins

A 41.1% decline brought Synopsys's net income down to $1.33B in FY2025 from $2.26B.

Net profit margin compressed to 18.9% in FY2025 from 36.9% in FY2024.

On a per-share basis, diluted earnings were $8.04 in FY2025 versus $14.51 in FY2024.

Explore the profitability trend in detail below

Synopsys Shareholder Returns

At present, Synopsys does not distribute a dividend to shareholders.

On the buyback front, Synopsys has spent $5.03B repurchasing shares over 9 years, reducing the float and boosting per-share metrics.

Explore Synopsys's capital return activity in the charts below

Balance Sheet Overview

Financial Position Summary (FY2025)
Metric Value
Cash & Short-term Investments $2.96B
Total Debt $13.48B
Shareholders' Equity $28.33B
Total Assets $48.22B
Debt-to-Equity Ratio 0.48x
Current Ratio 1.62x
Interest Coverage 2.0x
Free Cash Flow (TTM) $1.35B

Synopsys has a debt-to-equity ratio of 0.48, a current ratio of 1.62, interest coverage of 2.0x in FY2025, which suggest adequate financial health with manageable leverage.

Synopsys's balance sheet is in strong shape: $2.96B in cash against $13.48B in total debt, with a debt-to-equity ratio of 0.48x.

The current ratio of 1.62x indicates Synopsys can comfortably meet short-term obligations.

With interest coverage at 2.0x, Synopsys has enough earnings to meet its debt obligations, though not by a wide margin.

Free cash flow of $1.35B underscores Synopsys's ability to self-fund growth and return capital to shareholders.

See the detailed financial health breakdown in the charts

Synopsys employed 28,000 people as of FY2025, about $251.9K in revenue per employee.

See Synopsys's full employee count history and revenue per employee

Synopsys Valuation Analysis

Is Synopsys stock overvalued or undervalued? Here's what our valuation models suggest.

Synopsys shares are currently trading at $392.07.

The P/E Ratio model estimates an intrinsic value of $480, implying a 18.4% upside from the current price.

We also calculate intrinsic value using the DCF and EPS Growth models. Sign up to see the full breakdown with fair value estimates.

Valuation Models
Model Est. Fair Value vs. Current Price
P/E Ratio $480 18.4% upside to fair value
DCF Upgrade Upgrade
EPS Growth Upgrade Upgrade

Key Highlights

To sum up Synopsys's financial position: the data paints a clear picture for investors evaluating this information technology stock.

Revenue of $7.05B in FY2025, up 15.1% year-over-year.

Long-term revenue has been compounding at 12.1% annually over 10 years.

The company is profitable, with a net margin of 18.9% and net income of $1.33B.

Conservative balance sheet with a D/E ratio of 0.48x.

The P/E Ratio model implies 18.4% upside to fair value. The remaining 2 models are worth cross-checking before drawing a conclusion. Sign up to see the full analysis.

Scroll down for interactive charts covering Synopsys's full financial history and valuation models.

Frequently Asked Questions

What was Synopsys's revenue in FY2025?
Synopsys (SNPS) posted total revenue of $7.05B in FY2025.
How much does Synopsys earn per share?
Synopsys's diluted earnings per share (EPS) were $8.04 in FY2025.
Does Synopsys pay a dividend?
No, Synopsys does not currently pay a dividend.
What is the fair value of Synopsys stock?
Based on the P/E ratio model, Synopsys appears roughly fairly valued near its estimated fair value of $482.
What industry is Synopsys in?
Synopsys is in the Application Software industry within the Information Technology sector.

What does Synopsys do?

Synopsys provides electronic design automation (EDA) software and IP used to design, verify, and test integrated circuits and SoCs. Its core platforms — Fusion Design and Verification Continuum — cover digital implementation, simulation, emulation, and formal verification, while its IP portfolio spans high-speed interfaces (USB, PCIe, DDR, Ethernet) and processor cores. Synopsys also offers software security testing and application security solutions serving electronics, automotive, financial services, and industrial markets.

Detailed Charts

Synopsys Performance

5-year trend showing revenue, gross profit, and net profit

FY2021 – FY2025

Synopsys's revenue grew 15.1% to $7.05B in FY2025, but net profit declined 41.1% to $1.33B — indicating margin compression.

Understanding Company Performance

Revenue is Synopsys's total income from operations. Gross Profit is revenue minus cost of goods sold — the higher it is relative to revenue, the stronger the company's pricing power. Net Profit is the bottom line after all expenses, taxes, and interest. Consistent growth across all three signals a healthy, expanding business. Compare with peers in the same sector.

Is Synopsys Profitable?

5-year trend showing gross, operating, and net profit margins

FY2021 – FY2025

Synopsys's net profit margin of 18.9% in FY2025 reflects good profitability, with operating margin at 13.0% and gross margin at 77.0%.

Understanding Profitability Margins

Gross Profit Margin (GPM) shows what percentage of Synopsys's revenue remains after direct production costs. Operating Profit Margin (OPM) factors in operating expenses like R&D and SG&A. Net Profit Margin (NPM) is the final profitability after all costs including interest and taxes. Stable or improving margins indicate pricing power and cost discipline.

Synopsys Revenue & Earnings Growth

5-year trend showing revenue and diluted EPS

FY2021 – FY2025

Synopsys's revenue grew 15.1% YoY in FY2025, but EPS declined 44.6%, indicating margin pressure.

Understanding Revenue & Earnings Growth

Revenue is Synopsys's total income from operations — the top line. Diluted EPS (Earnings Per Share) is net income divided by all shares that could exist if stock options, RSUs, and convertibles were exercised. Revenue shows how fast the business is growing; EPS shows how much of that growth reaches shareholders after all costs and dilution. Healthy companies tend to grow both in tandem; when revenue grows but EPS shrinks, margins are compressing. Use our stock screener to compare growth profiles across companies.

Synopsys Compound Annual Growth Rate (CAGR)

Metric 1-Year 5-Year 10-Year
Revenue +15.1% +13.9% +12.1%
Net Income -41.1% +14.9% +19.4%
EPS -44.6% +13.5% +18.8%
Share Price -36.6% +6.3% +21.8%

Synopsys's 10-year revenue CAGR of 12.1% reflects healthy long-term growth, with EPS CAGR of 18.8% outpacing revenue, indicating improving profitability. The share price has compounded at 21.8% annually over a comparable period, broadly tracking fundamentals.

Synopsys Quarterly Performance

Quarterly revenue and net income with a weekly share-price overlay

Upgrade to see the full 5 years (20 quarters) of quarterly data.

FY2025 – FY2026

How to Read Quarterly Performance

Quarterly revenue and net income are Synopsys's most recent three-month results. Each bar shows net income nested inside revenue, since profit is the slice of revenue left after all costs; the taller the green portion relative to the blue, the more of each sales dollar reached the bottom line. A bar below zero is a quarterly loss.

For a long-term view, compare each quarter with the same quarter a year earlier (year-over-year), not with the previous quarter — sequential change is mostly seasonality (for many businesses the holiday quarter is always the biggest). Then watch the trend across several years: is year-over-year revenue growth accelerating or fading; is net income growing at least as fast as revenue (expanding vs compressing margins)? One quarter is noise — the multi-quarter trend is the signal.

Synopsys Share Price vs Book Value

Synopsys (SNPS) share price vs book value per share — FY2016 – FY2025

Understanding Share Price vs Book Value

Share Price is what the market pays per share of Synopsys. Book Value per Share (BVPS) is the company's net equity divided by diluted shares — the accounting floor if the company were liquidated today. When price tracks close to book value the market sees the company as a steady asset; when price runs far above book the market is paying up for expected future earnings. For banks, book value is the primary valuation anchor; for most other companies it's one signal among many.

Unlock Valuation Analysis

Get fair value estimates from multiple valuation models and see whether a stock is undervalued or overvalued.

  • Multi-model fair value estimates (P/E, DCF, EPS Growth)
  • Undervalued/overvalued assessment with upside potential
  • Compare fair values across methodologies

Synopsys Free Cash Flow

5-year trend — cash generated after reinvestment

FY2021 – FY2025

Synopsys's free cash flow of $1.35B in FY2025 represents a 19.1% FCF margin — healthy cash generation supporting dividends, buybacks, or debt reduction.

Understanding Free Cash Flow

Free Cash Flow (FCF) is Synopsys's operating cash flow minus capital expenditure — the cash left over after maintaining and growing the business. Unlike net profit, FCF strips out non-cash items (depreciation, stock-based compensation) and includes actual cash spent on assets. Positive FCF means the company can pay dividends, buy back shares, reduce debt, or make acquisitions without raising capital. Consistently negative FCF signals the company is burning cash and may need external funding.

Synopsys Financial Ratios

Balance sheet strength and debt servicing capacity

FY2021 – FY2025

Debt-to-Equity

0.48

▲ from 0.00

Current Ratio

1.62

▼ from 2.44

Interest Coverage

2.0x

▼ from 36.8x

Synopsys has a debt-to-equity ratio of 0.48, a current ratio of 1.62, interest coverage of 2.0x in FY2025, which suggest adequate financial health with manageable leverage.

Understanding Financial Health

Debt-to-Equity (D/E) measures how much debt the company carries relative to shareholder equity — lower means less leverage risk. Current Ratio divides current assets by current liabilities — above 1.0 means the company can cover short-term obligations. Interest Coverage is operating income divided by interest expense — higher means the company earns well above its debt payments. Together these three metrics reveal whether a company can weather downturns without financial distress.

Synopsys Shares Outstanding

Diluted share count per fiscal year — labels show year-over-year change

FY2021 – FY2025

Synopsys's diluted shares grew 3.7% YoY in FY2025, reflecting noticeable dilution often tied to SBC at growth-stage companies or capital raises.

Understanding Shares Outstanding

Diluted shares outstanding counts every share of Synopsys that could exist if all stock options, RSUs, and convertibles were exercised. A shrinking count signals buybacks (returning cash to shareholders by reducing the denominator of EPS). A growing count signals dilution — usually from stock-based compensation, secondary offerings, or stock-funded acquisitions. Routine 1–2% growth is typical at large-cap tech companies that pay employees in equity; sustained growth above 5% warrants a look at the cause.

Unlock Full Analysis

Unlock 10-year interactive charts, all 5 valuation models, and full screener access.

Related Stocks